Literature DB >> 12557960

Steroid sensitive nephrotic syndrome.

H M Nanjundaswamy1, K D Phadke.   

Abstract

Nephrotic syndrome in children is a common recurrent disease. Most of the cases are due to minimal change disease with a favourable outcome. More than 90% of children with minimal change disease respond to corticosteroid therapy (steroid sensitive nephrotic syndrome). 40-60% experience frequent relapses or have steroid dependence. These children require frequent corticosteroid therapy and/or immunomodulators or treatment with immunosuppressants, and are at high risk of cumulative steroid toxicity and side effects of cytotoxic therapy. Children with frequent relapses or steroid dependence should be managed in consultation with a pediatric nephrologist. Despite relapsing course, progression of minimal change nephrotic syndrome to end stage renal disease is extremely rare.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12557960     DOI: 10.1007/BF02724388

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  12 in total

Review 1.  Consensus statement on management of steroid sensitive nephrotic syndrome.

Authors: 
Journal:  Indian Pediatr       Date:  2001-09       Impact factor: 1.411

2.  Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.

Authors:  B K Ekka; A Bagga; R N Srivastava
Journal:  Pediatr Nephrol       Date:  1997-10       Impact factor: 3.714

3.  Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome.

Authors:  A Takeda; H Takimoto; Y Mizusawa; M Simoda
Journal:  Pediatr Nephrol       Date:  2001-11       Impact factor: 3.714

Review 4.  Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians.

Authors: 
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

5.  Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children.

Authors: 
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

6.  Levamisole therapy in corticosteroid-dependent nephrotic syndrome.

Authors:  A Bagga; A Sharma; R N Srivastava
Journal:  Pediatr Nephrol       Date:  1997-08       Impact factor: 3.714

7.  A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome.

Authors:  M Broyer; F Terzi; A Lehnert; M F Gagnadoux; G Guest; P Niaudet
Journal:  Pediatr Nephrol       Date:  1997-08       Impact factor: 3.714

8.  Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials.

Authors:  E M Hodson; J F Knight; N S Willis; J C Craig
Journal:  Arch Dis Child       Date:  2000-07       Impact factor: 3.791

9.  Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome.

Authors:  A M Wingen; D E Müller-Wiefel; K Schärer
Journal:  Clin Nephrol       Date:  1985-01       Impact factor: 0.975

10.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.